Omega announced that the Nigerian Ministry of Health has approved its VISITECT CD4 350 diagnostic test, thereby paving the way for first shipments to its distributor, which has already placed orders for 250k tests with a value of c.£1.0m. Pending confirmation of actual delivery dates, our forecasts assume c.£0.5m is booked in the current financial year, rising to c.£2m in FY 2021 as the expected approval of VISITECT CD4 under the WHO Pre-Qualification programme in 2020 will
17 Jan 2020
Omega Diagnostics - Nigerian approval of VISITECT
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Omega Diagnostics - Nigerian approval of VISITECT
Cambridge Nutritional Sciences PLC (CNSL:LON) | 3.6 0 0.0% | Mkt Cap: 8.69m
- Published:
17 Jan 2020 -
Author:
Mark Brewer | Cavendish Research -
Pages:
3
Omega announced that the Nigerian Ministry of Health has approved its VISITECT CD4 350 diagnostic test, thereby paving the way for first shipments to its distributor, which has already placed orders for 250k tests with a value of c.£1.0m. Pending confirmation of actual delivery dates, our forecasts assume c.£0.5m is booked in the current financial year, rising to c.£2m in FY 2021 as the expected approval of VISITECT CD4 under the WHO Pre-Qualification programme in 2020 will